Sunesis Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Covering Vosaroxin Compositions – msnbc.com

The VALOR logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8774 . About Vosaroxin Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), a class of compounds that has not been used previously for the …